Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 301 - 330 of 368
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Treposa 5 mg - ml infuusioneste, liuos SPC 2023-10-17
PL	Resepti	Treprostinil Tillomed 1 mg - ml infuusioneste, liuos SPC 2023-06-21
PL	Resepti	Treprostinil Tillomed 10 mg - ml infuusioneste, liuos SPC 2023-06-21
PL	Resepti	Treprostinil Tillomed 2.5 mg - ml infuusioneste, liuos SPC 2023-06-21
PL	Resepti	Treprostinil Tillomed 5 mg - ml infuusioneste, liuos SPC 2023-06-21
		European Medicines Agency's website: Trepulmix - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Tresiba - EMA: EPAR PI Finnish Swedish
PL	Resepti	Trevicopto 40 mikrog - ml silmätipat, liuos, kerta-annospakkaus SPC 2024-07-11
PL	Resepti	Trevicopto Comp 40 mikrog/ml + 5 mg/ml silmätipat, liuos, kerta-annospakkaus SPC 2024-11-06
		European Medicines Agency's website: Trevicta - EMA: EPAR PI Finnish Swedish
PL	Resepti	Trexan 2.5 mg, 10 mg tabletti SPC 2023-02-01
PL	Resepti	Trexan 25 mg_ml injektioneste, liuos, esitäytetty ruisku valmisteyhteenveto 2023-01-17
PL	Resepti	Triaxis injektioneste, suspensio, esitäytetty ruisku SPC 2023-03-27
PL	Resepti	Trica 20 mg-ml injektioneste, suspensio PL 2022-10-10
PL	Resepti	Trica 20 mg-ml injektioneste, suspensio SPC 2022-12-05
PL	Itsehoito	Tricovivax 50 mg-ml liuos iholle SPC 2024-10-31
PL	Resepti	Trientine Tillomed 167 mg kapseli, kova SPC 2023-08-11
PL	Resepti	Trientine Waymade 200 mg kapseli, kova SPC 2023-02-07
PL	Resepti	Triesence 40 mg-ml injektioneste, suspensio SPC 2023-06-21
PL	Resepti	Trikozol 400mg tabletti SPC 2022-11-24
PL	Resepti	Trilaham 5, 25, 50, 100, 200 mg dispergoituva tabletti SPC 2004-06-14
PL	Resepti	Trilandia 5, 25, 50, 100, 200 mg dispergoituva tabletti SPC 2004-06-14
PL	Resepti	Trileptal 150 mg, 300 mg, 600 mg tabletti, kalvopäällysteinen SPC 2024-11-01
PL	Resepti	Trileptal 60 mg-ml oraalisuspensio SPC 2024-11-01
		European Medicines Agency's website: Trimbow - EMA: EPAR PI Finnish Swedish
PL	Resepti	TRIMETIN 100 mg, 160 mg, 300 mg tabletti SPC 2022-11-01
PL	Resepti	TRIMETIN 100 mg, 160 mg, 300 mg tabletti SPC 2022-11-01
PL	Resepti	Trimopan 10 mg-ml oraalisuspensio SPC 2022-08-30
PL	Resepti	Trimopan 100 mg, 160 mg tabletti, kalvopäällyinen, Trimopan 300 mg tabletti SPC 2022-08-30
PL	Resepti	TrioBe tabletti SPC 2023-09-19
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >